Does SARILUMAB Cause Hypercholesterolaemia? 697 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 697 reports of Hypercholesterolaemia have been filed in association with SARILUMAB (KEVZARA). This represents 3.2% of all adverse event reports for SARILUMAB.
697
Reports of Hypercholesterolaemia with SARILUMAB
3.2%
of all SARILUMAB reports
678
Deaths
562
Hospitalizations
How Dangerous Is Hypercholesterolaemia From SARILUMAB?
Of the 697 reports, 678 (97.3%) resulted in death, 562 (80.6%) required hospitalization, and 582 (83.5%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SARILUMAB. However, 697 reports have been filed with the FAERS database.
What Other Side Effects Does SARILUMAB Cause?
Drug ineffective (5,065)
Pain (4,833)
Arthralgia (4,139)
Rheumatoid arthritis (3,963)
Joint swelling (3,951)
Condition aggravated (3,247)
Fatigue (3,000)
Rash (2,912)
Alopecia (2,660)
Abdominal discomfort (2,600)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which SARILUMAB Alternatives Have Lower Hypercholesterolaemia Risk?
SARILUMAB vs SATRALIZUMAB
SARILUMAB vs SATRALIZUMAB-MWGE
SARILUMAB vs SAXAGLIPTIN
SARILUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SARILUMAB vs SCOPOLAMINE